Every May, Brain Tumor Awareness Month marks an important opportunity for the brain cancer community to raise awareness and encourage action. As a member of that community, Novocure took steps to support the initiative by launching a Public Service Announcement (PSA), promoting the PSA on social media, sponsoring a Q&A with glioblastoma (GBM) patients and attending several advocacy events.
“Brain Tumor Awareness Month is not just about increasing the public’s knowledge about brain cancer, but also empowering patients with information and tools to take action,” said Pritesh Shah, Senior Vice President of the Americas at Novocure.
Novocure kicked off BTAM by launching a PSA created in partnership with The Creative Coalition, a nonprofit organization focused on arts advocacy. In the PSA, celebrities and artists discuss how their work has the power to inspire action. Marcia Miller, one of the artists featured, is a GBM patient.
“As an artist living with brain cancer, the creative process is not just my happy place, it’s my absolute passion,” Marcia said. “My art is the authentic reflection of who I am. I feel empowered by sharing my passion.”
Taylor Gray, who has GBM, participates in a brain tumor advocacy walk in Charleston, South Carolina.
As an artist living with brain cancer, the creative process is not just my happy place, it’s my absolute passion.
Marcia Miller, GBM patient
Marcia appreciated the opportunity to not only share her passion for the arts, but also for her and her husband B.T. to work with Novocure.
“We continuously marvel at the quality of people employed by Novocure,” Marcia said. “We wish we could personally meet each and every one to express how much we appreciate what they do for GBM patients and caregivers.”
Novocure promoted the PSA via a Thunderclap, which is an online tool that enables many users to post the same post on multiple social media platforms at the same time. Like voices in a chorus, speaking together in unison helps to amplify the volume of the message. Over 140 people participated in the Thunderclap with a reach of over 1.3 million.
Novocure also participated in several advocacy events. Some of the activities highlighted included participating in a Novocure-sponsored Q&A with Novocure patients as well as over 10 advocacy walks where Novocure had a presence. Novocure also showed support via attendance at a Partners in Treatment Care event from the American Brain Tumor Association, the National Brain Tumor Society’s Head to the Hill event and the End Brain Cancer Initiative’s Brains Matter dinner.
Pritesh Shah, Novocure's Senior Vice President of the Americas, said BTAM is a chance to raise awareness and empower patients to take action.
Daniel Dipsia, a PharmD Marketing Fellow, braved the rain to attend a Head for the Cure Walk in New York and also walked alongside one of Novocure’s patients in Charleston, South Carolina.
“It was extremely rewarding to plan and participate in several of the events that occurred during Brain Tumor Awareness Month,” Daniel said. “To hear patients and caregivers share their stories and to join my colleagues in showing their support for the brain cancer community was inspiring. I’m proud to be a part of an organization that I believe is making a difference.”
Novocure employees participate in a brain tumor advocacy walk in New York City.
I’m proud to be a part of an organization that I believe is making a difference.
Daniel Dipsia, a PharmD Marketing Fellow at Novocure
novocuretrial.com The science of Tumor Treating Fields extends beyond glioblastoma and mesothelioma. Novocure has ongoing or completed clinical trials investigating our therapy in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.